Sivers Semiconductors: Insider Probe Casts Shadow Over Nasdaq Ambitions and 1,200% Rally

Sivers Semiconductors sees a 1,200% rally but faces insider trading investigation, accounting restatements, and a capital raise as it pursues a dual Nasdaq listing.

The numbers are staggering — a 47% single-day surge, a year-to-date gain of over 1,200%, and a valuation that towers 31 times revenue against a sector average of just four times. But behind Sivers Semiconductors' breathtaking rally lies a tangle of regulatory scrutiny, accounting overhauls, and a capital raise that will test investor conviction.

Sweden's Economic Crime Authority has opened an investigation into potential insider trading, focusing on whether confidential details about the company's planned secondary listing on the Nasdaq New York leaked before the official announcement in April. A prosecutor is now examining the case, adding a legal dimension to what was already shaping up as a defining period for the photonics and semiconductor specialist.

Capital Raise and Nasdaq Pivot

The US listing ambitions are the engine behind much of the recent excitement. Sivers intends to pursue a dual listing on the Nasdaq New York while keeping its corporate headquarters in Sweden, a move designed to tap deeper pools of American technology capital and broaden its international shareholder base. The stock closed at 55.95 SEK on the Nasdaq Stockholm following the announcement.

To fund the transition, the company is pushing ahead with a targeted share issue. Shareholders will vote on 11 May on a private placement of 8.62 million new shares at 14.50 SEK each, aiming to raise approximately 125 million Swedish kronor before costs. Three institutional investors — DNB Disruptive Opportunities, DNB Nordic Small Cap, and Storebrand Sverigefond — have already committed to the deal. If approved, existing holders face dilution of roughly 2.5% on a fully diluted basis. In return, management has agreed to a 90-day lock-up period.

CEO Vickram Vathulya plans to channel the proceeds into accelerating product development, strengthening the sales force, and shoring up the balance sheet. The financial buffer is badly needed: while annual revenue climbed a quarter to just over 304 million SEK, the company still posted a net loss of approximately 186 million SEK.

Accounting Adjustments and Delayed Reporting

The path to a US listing is proving administratively demanding. Sivers must restate its 2024 and 2025 financial statements to comply with PCAOB standards — the rigorous US accounting framework for publicly traded companies. The review is still underway and could trigger adjustments in revenue recognition between periods, inventory valuations, and stock option programs. Management insists none of the changes will have a material impact on the company's financial position.

Nevertheless, the PCAOB audit has pushed back the reporting calendar. The 2025 annual report, originally due on 27 April, will now be published on 15 May. The annual general meeting has been rescheduled from late May to 15 June. First-quarter 2026 results are slated for 20 May, creating a tight window of financial disclosures that will provide the first real test of the stock's current valuation.

Competitive Pressure and Strategic Partnerships

While Sivers pursues its US ambitions, competitors are not standing still. Industry heavyweight Nvidia recently poured $2 billion each into photonics specialists Lumentum and Coherent, underscoring the escalating arms race in optical technology. Sivers is betting on its partnership with Jabil to develop a new receiver for optical transceivers based on its proprietary laser technology — a collaboration that could prove pivotal in defending its market position.

The valuation leaves little room for error. At 31 times revenue, Sivers trades at a massive premium to both the broader European semiconductor sector (4 times) and comparable peers (17.5 times). For a company still generating losses, the market is pricing in extraordinary growth fueled by the AI boom and the successful execution of the US listing.

The next two weeks will be decisive. With the PCAOB-certified annual report due on 15 May, followed by first-quarter numbers on 20 May, management must deliver results that justify the hype — before shareholders gather on 15 June to chart the company's next chapter.